abrdn-Nrth American Sml Comp X Acc GBP
North American Smaller CompaniesPricing frequency
Daily
Dealing cut off time
10:45
Type
SICAV
Yield
–
NAV
£19.6901
Income frequency
-
Ongoing charge
0.92%
Latest actual NAV date
16-11-2026
ISIN
LU2015249035
UCITS
Yes
Growth of 10k
Asset allocation
Top 10 holdings
| Holdings 31/10/2026 | % of assets |
|---|---|
| Kiniksa Pharmaceuticals International PLC Class A | 2.98 |
| Magnolia Oil & Gas Corp Class A | 2.94 |
| Q2 Holdings Inc | 2.83 |
| Wintrust Financial Corp | 2.71 |
| Ligand Pharmaceuticals Inc | 2.55 |
| WSFS Financial Corp | 2.51 |
| Supernus Inc | 2.49 |
| Merit Medical Systems Inc | 2.42 |
| Ameris Bancorp | 2.35 |
| AZZ Inc | 2.30 |
Investment objective
The Fund’s investment objective is long term total return to be achieved by investing at least 70% of the Fund’s assets in small capitalisation equities and equity-related securities of companies listed, incorporated or domiciled in the United States of America (USA) or Canada or companies that derive a significant proportion of their revenues or profits from US or Canadian operations or have a significant proportion of their assets there. The Fund is actively managed. The Fund aims to outperform the Russell 2000 Index (USD) benchmark before charges. The benchmark is also used as a reference point for portfolio construction and as a basis for setting risk constraints, but does not incorporate any sustainable criteria.
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.